Latest / Medicine Matters: The Springer Medicine Podcast
Episode 29: A new era for Sjögren disease
How emerging research is poised to reshape care
Sjögren disease is the second most common autoimmune rheumatic disease, but despite decades of research, no disease-modifying therapies are approved for the condition, and patient care relies on symptom management and immunomodulation.
Change is on the horizon, however, and recent progress in understanding disease pathogenesis has opened the door to developing targeted therapies that are showing promise in clinical trials. We speak with Prof. Raphaèle Seror about the research driving the transformation, the recent update in nomenclature, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.